Navigation Links
Tulane receives $15 million NIH contract to develop vaccine and treatment for deadly fever
Date:2/9/2010

The National Institute of Allergies and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded a five-year contract totaling $15,254,919 to Tulane University for its ongoing efforts to treat and prevent Lassa fever, an often deadly viral disease that threatens hundreds of thousands of people annually in West Africa and is classified as a potential bioterrorism threat.

The contract will include collaboration between Tulane; Scripps Research Institute; The Broad Institute; Harvard University; the University of California at San Diego; Boston University; Autoimmune Technologies, LLC; Corgenix Medical Corporation and various partners in West Africa.

Dr. James Robinson, professor of pediatrics at Tulane University School of Medicine and principal investigator of the program, said researchers plan to evaluate antibodies from patients who were infected by the Lassa virus and recovered, to see if those antibodies might play a role in the development of a vaccine or treatment for the illness.

"This study will result in a fundamental understanding of the mechanisms of antibody responses and how they neutralize the Lassa virus," Robinson said. "We have assembled a very strong and diverse group of institutions to collaborate on this project."

In some areas of Sierra Leone, up to 16 percent of people admitted to hospitals have Lassa fever. Lassa fever is also associated with occasional epidemics, during which the fatality rate can reach 50 percent.

But Dr. Robert Garry, professor of microbiology and immunology at Tulane, who serves as program manager of the contract, sees hope.

"We have been very pleased with the results of our research efforts over the past five years," he said. "The diagnostic products we have developed have been shown to be remarkably effective in clinical settings in Africa, and will not only have a meaningful impact on health care in that part of the world, but wi
'/>"/>

Contact: Arthur Nead
anead@tulane.edu
Tulane University
Source:Eurekalert

Page: 1 2

Related biology news :

1. Tulane receives grant to study limb regeneration
2. Carnegie Mellons John Kitchin receives early career award
3. Jedi Mind Receives Vast Media Coverage at CES in Las Vegas
4. University of Maryland School of Medicine receives $30 million to coordinate stem cell consortium
5. GenWay Clinical Laboratory receives accreditation from College of American Pathologists
6. Editor of Springer classic human genetics reference receives prize
7. Lehigh University professor receives Astellas Award for arsenic groundwater remediation efforts
8. University of California, San Francisco, researcher receives ASBMB-Merck Award
9. IGC scientist receives prestigious EMBO installation grant
10. UT Southwestern receives $700,000 from HHMI to promote medical education of Ph.D. students
11. Einstein receives high-risk/high-reward cancer research funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... in the Cell Press journal Current Biology ... rather novel sex lives. The Brazilian insects, which represent ... Neotrogla , are the first example of an animal ... been identified in several different animals, Neotrogla ... is also reversed," says Kazunori Yoshizawa from Hokkaido University ...
(Date:4/17/2014)... Medical Branch at Galveston are the first to ... cervical cancer should begin colorectal cancer screening earlier ... finding a high incidence of secondary colorectal cancers ... new recommendations that the younger women in this ... after their initial cervical cancer diagnosis instead of ...
(Date:4/17/2014)... researchers, led by the Australian National University (ANU), ... changes and deep-sea temperature variability over the past ... better understand the climate surrounding ice ages over ... determine the relationship between carbon dioxide levels, global ... the University of Southampton (UoS) and the National ...
Breaking Biology News(10 mins):In sex-reversed cave insects, females have the penises 2Radiation therapy for cervical cancer increases risk for colorectal cancer 2Ancient sea-levels give new clues on ice ages 2
... Western Europe,s largest lakes, Lake Geneva, in large enough quantities ... that these small bits of plastic can be harmful to ... waterborne organisms, the full extent of their consequences in lakes ... is being extending under a mandate by the Swiss Federal ...
... paper published in the Journal of Animal Science ... when including distillers dried grains with solubles (DDGS). Some ... the fat-softening effects of DDGS. Firmer fat means longer-lasting ... found that including saturated fats in DDGS diets makes ...
... to threaten common ash trees across Europe, new research in ... impact of forest diseases to discover if diseases played a ... large-scale pathogen outbreaks were much more infrequent in the past, ... locations, such as the international seed trade, is a major ...
Cached Biology News:Microplastic pollution prevalent in lakes too 2Microplastic pollution prevalent in lakes too 3Saturated fats do not yield better bacon 2
(Date:1/15/2014)... TaiGen Biotechnology Company, Limited ("TaiGen") today announced that ... leading Russian pharmaceutical company, to develop and commercialize nemonoxacin ... , Turkey and other ... novel antibiotic for the treatment of bacterial infections including ...
(Date:1/14/2014)... 2014 Histogen, Inc., a regenerative medicine ... grown under simulated embryonic conditions, today announced that they ... Medical, Inc. for physician-dispensed aesthetic products containing Histogen’s proprietary ... agreement is an amendment to the existing license between ...
(Date:1/14/2014)... 14, 2014 EquitiesIQ, a leading informational ... ALQA). Alliqua is an emerging biomedical company acquiring, developing, ... care market. , Free report download: http://equitiesiq.com/reports/alliqua/ ... seasoned management team and Board, which launched the company’s ...
(Date:1/14/2014)... iLab Solutions, the leader in core facility management software, ... Strategy. In this role, Michelle will work with current and ... the development of iLab products. Her main goal will be ... the scientific community by offering the most advanced, user-friendly, and ...
Breaking Biology Technology:TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2
... Onyx,Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced ... executive officer and a member of,the company,s board of ... Renton, who announced his retirement plans last,October. Mr. Renton ... of the Onyx Board of Directors on the same ...
... 2008 9:15 am ET, MOUNTAINSIDE, N.J., Feb. ... NHGI) today announced that its President,Michael Cohen will ... Government Agencies, Academic Institutions and Development Stage,Biotech Companies," ... Partnering,Series: Fostering Business Collaborations & Careers in Stem ...
... Senetek PLC (OTC,Bulletin Board: SNKTY), a Life Sciences company ... of healthy aging, today announced,that results of a clinical ... of the Journal of Drugs in Dermatology., The ... of,topical Pyratine-6(TM) over 12 weeks for improving the baseline ...
Cached Biology Technology:Onyx Pharmaceuticals Names N. Anthony Coles, M.D. as President, Chief Executive Officer and Member of its Board of Directors 2Onyx Pharmaceuticals Names N. Anthony Coles, M.D. as President, Chief Executive Officer and Member of its Board of Directors 3National Stem Cell Holding, Inc. to Present Keynote Address at The Stem Cell Partnering Series Inaugural Meeting in San Diego 2National Stem Cell Holding, Inc. to Present Keynote Address at The Stem Cell Partnering Series Inaugural Meeting in San Diego 3Pyratine-6(TM) Study Published in Journal of Drugs in Dermatology 2Pyratine-6(TM) Study Published in Journal of Drugs in Dermatology 3